HCAT R&D to Revenue
Health Catalyst Inc · R&D to Revenue
HCAT R&D to Revenue
Latest reported15.64%period ending
HCAT Quarterly R&D/Revenue (42.19% → 15.64%)
Latest values, visible window
High-resolution chart · PNG
HCAT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.6426% | |
| 13.6709% | |
| 13.2715% | |
| 16.0908% | |
| 15.3516% | |
| 19.1228% | |
| 18.8453% | |
| 18.5887% | |
| 18.292% | |
| 19.9015% | |
| 27.0204% | |
| 23.9478% | |
| 24.0258% | |
| 23.125% | |
| 28.3595% | |
| 30.3859% | |
| 25.6934% | |
| 25.1854% | |
| 27.0088% | |
| 26.54% | |
| 24.3581% | |
| 25.6867% | |
| 28.1124% | |
| 28.3741% | |
| 27.8809% | |
| 29.0097% | |
| 29.9832% | |
| 34.1856% | |
| 26.383% | |
| 28.4611% | |
| 29.2678% | |
| 32.9774% | |
| 36.9161% | |
| 42.1917% |